Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 6

Diffusion tensor imaging findings of patients withparkinson’s disease refractory to medical treatment

Pages
1223–1227
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Study group FA values were significantly lower than the control groupin all areas bilaterally (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Diffusion Tensor Imaging (DTI) findings can be useful to detect and measure neurodegeneration that is seen in Parkinson’sdisease (PD).
📊
Key Findings & Data:Materials and Methods: The study includes 18 PD patients who were candidates for deep brain stimulation surgery, and 19 controlgroup patients.
💡
Conclusion & Impact:Study group FA values were significantly lower than the control groupin all areas bilaterally (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Diffusion Tensor Imaging (DTI) findings can be useful to detect and measure neurodegeneration that is seen in Parkinson’sdisease (PD). Microstructural changes in regions of the brain related with motor function are evaluated by using DTI measurementsof fractional anisotropy (FA) to find out the possible role of the technique in diagnosis in patients with PD. Materials and Methods: The study includes 18 PD patients who were candidates for deep brain stimulation surgery, and 19 controlgroup patients. DTI was performed in all cases. DTI characteristics of FA were measured in primary motor cortex (M1), supplementarymotor area (SMA), inferior parietal lobule, putamen (P), globus pallidus externus (GPe) and internus (GPi), ventrolateral nucleus ofthalamus (Th), substantia nigra (SN), cuneus, precuneus and cerebellar dentate nucleus (D) bilaterally. Additionally, we processed“raw” FA images and colored them according to fiber orientation to visualize STN and GPi nuclei. Results: Mean age of the control group was 59.2±13.2 (range: 31-79) years, while it was 56.7±16 (range: 42-77) years for the patientgroup. Mean duration of PD was 12.4±7.1 (range: 5-30) years. Study group FA values were significantly lower than the control groupin all areas bilaterally (p

🔖

Cite This Article

GÜDÜK, M., UYANIK, S. A., ÇENKERİ, H. Ç., ATLI, E., ÖĞÜŞLÜ, U., YILMAZ, B., GÜMÜŞ, B., YILMAZ, A. (2022). Diffusion tensor imaging findings of patients withparkinson’s disease refractory to medical treatment. Annals of Medical Research, Cilt: 28 - Sayı: 6, 1223–1227. https://ajindex.com/articles/445698

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Tessa C, Giannelli M, Della Nave R, et al. A whole-brain analysis in de novo Parkinson disease. AJNR Am J Neuroradiol 2008;29:674-80
  2. Chen N-K, Chou Y-H, Sundman M, et al. Alteration of Diffusion-Tensor Magnetic Resonance Imaging Measures in Brain Regions Involved in Early Stages of Parkinson’s Disease. Brain Connect 2018;8:343-9
  3. Gaudiello F, Garaci F, Marziali S, et al. Evaluation of basal ganglia haemodynamic changes with perfusionweighted magnetic resonance imaging in patients with Parkinson’s disease. Radiol Med 2006;111:284- 90
  4. Marek KL, Seibyl JP, Zoghbi SS, et al. [123I] betaCIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson’s disease. Neurology 1996;46:231-7
  5. Benamer HTS, Patterson J, Grosset DG, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123 I]-FP-CIT SPECT imaging: The [123 I]-FP-CIT study group. Mov Disord 2000;15:503-10
  6. Borghammer P, Vafaee M, Ostergaard K, et al. Effect of memantine on CBF and CMRO2 in patients with early Parkinson’s disease. Acta Neurol Scand 2008;117:317–23
  7. Perlmutter JS, Raichle ME. Regional blood flow in herniparkinsonism. Neurology 1985;35:1127
  8. Stoessl AJ, Lehericy S, Strafella AP. Imaging insights into basal ganglia function, Parkinson’s disease, and dystonia. Lancet (London, England). 2014;384:532– 44
  9. Saeed U, Compagnone J, Aviv RI, et al. Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts. Transl Neurodegener 2017;6:8
  10. Hope TR, Selnes P, Rektorová I, et al. Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson’s disease. PLoS One. 2019;14:e0217922
  11. Sedrak M, Gorgulho A, Bari A, et al. Diffusion tensor imaging (DTI) and colored fractional anisotropy (FA) mapping of the subthalamic nucleus (STN) and the globus pallidus interna (GPi). Acta Neurochir (Wien) 2010;152:2079-84
  12. Nagae LM, Honce JM, Tanabe J, et al. Microstructural Changes within the Basal Ganglia Differ between Parkinson Disease Subtypes. Front Neuroanat 2016;10:17
  13. Surova Y, Szczepankiewicz F, Lätt J, et al. Assessment of Global and Regional Diffusion Changes along White Matter Tracts in Parkinsonian Disorders by MR Tractography. Zhan W, editor. PLoS One. 2013;8:e:66022
  14. Heim B, Krismer F, De Marzi R, et al. Magnetic resonance imaging for the diagnosis of Parkinson’s disease. J neural Transm 2017;124:915-64. 15.